Exactly rstar, and I also think that clue about Dr. Matthan's new contract entailing him transferring the ongoing behind the scenes trials into commercialization scale joint ventures, was a HUGE component of Mondays premarket release that isn't getting much air time yet...but to me could soon be proven to be a huge driver of his new contract capabilities/responsibilities in the post Rotmans leverage era upon us;)
News 
Market Data 
Discover 
